|
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2027
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
|
National Institutes of Health |
October 14, 2027
|
— |
Nonprofits
|
|
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 16, 2027
|
— |
Nonprofits
|
|
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
|
National Institutes of Health |
October 18, 2027
|
— |
Nonprofits
|
|
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2027
|
$300k |
Nonprofits
|
|
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2027
|
$650k |
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
$750k |
Nonprofits
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
$750k |
Nonprofits
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
— |
Nonprofits
|
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
|
National Institutes of Health |
October 25, 2027
|
$375k |
|
|
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
|
National Institutes of Health |
November 5, 2027
|
— |
|
|
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
|
National Institutes of Health |
November 5, 2027
|
$1.5M |
Nonprofits
|
|
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
|
National Institutes of Health |
November 5, 2027
|
— |
Nonprofits
|
|
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 8, 2027
|
— |
Nonprofits
|
|
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 12, 2027
|
$350k |
Nonprofits
|
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
|
National Institutes of Health |
November 12, 2027
|
— |
Nonprofits
|
|
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 12, 2027
|
— |
Nonprofits
|
|
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
|
National Institutes of Health |
November 12, 2027
|
— |
Nonprofits
|
|
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
|
National Institutes of Health |
November 15, 2027
|
$6.2M |
Nonprofits
|
|
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 15, 2027
|
— |
Nonprofits
|
|
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
|
National Institutes of Health |
November 16, 2027
|
$200k |
Nonprofits
|
|
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 16, 2027
|
$100k |
Nonprofits
|
|
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 16, 2027
|
— |
Nonprofits
|
|
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
|
National Institutes of Health |
November 16, 2027
|
— |
Nonprofits
|
|
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 16, 2027
|
— |
Nonprofits
|
|
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 18, 2027
|
$300k |
Nonprofits
|
|
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
|
Dept of the Army -- Materiel Command |
November 20, 2027
|
— |
|
|
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
December 3, 2027
|
— |
Nonprofits
|
|
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
December 3, 2027
|
— |
Nonprofits
|
|
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
|
National Institutes of Health |
December 23, 2027
|
$350k |
Nonprofits
|
|
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
|
National Institutes of Health |
December 23, 2027
|
— |
Nonprofits
|
|
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
|
National Institutes of Health |
December 23, 2027
|
— |
Nonprofits
|
|
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
|
National Institutes of Health |
December 23, 2027
|
— |
Nonprofits
|
|
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
|
National Institutes of Health |
December 23, 2027
|
— |
Nonprofits
|
|
CONTAMINATED ALASKA NATIVE CLAIMS SETTLEMENT ACT LANDS ASSISTANCE PROGRAM
|
Environmental Protection Agency |
December 31, 2027
|
$3M |
|
|
NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
|
National Park Service |
December 31, 2027
|
$0 |
|